Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Times Interest Earned (2021 - 2025)

Verrica Pharmaceuticals has reported Times Interest Earned over the past 5 years, most recently at -$5.47 for Q4 2025.

  • Quarterly results put Times Interest Earned at -$5.47 for Q4 2025, down 12.68% from a year ago — trailing twelve months through Dec 2025 was -$1.57 (up 77.53% YoY), and the annual figure for FY2025 was -$1.57, up 77.53%.
  • Times Interest Earned for Q4 2025 was -$5.47 at Verrica Pharmaceuticals, down from $0.78 in the prior quarter.
  • Over the last five years, Times Interest Earned for VRCA hit a ceiling of $17.88 in Q3 2022 and a floor of -$14.43 in Q3 2023.
  • Median Times Interest Earned over the past 5 years was -$6.85 (2022), compared with a mean of -$5.06.
  • Peak annual rise in Times Interest Earned hit 265.88% in 2022, while the deepest fall reached 11833.64% in 2022.
  • Verrica Pharmaceuticals' Times Interest Earned stood at -$7.72 in 2021, then soared by 331.53% to $17.88 in 2022, then tumbled by 156.15% to -$10.04 in 2023, then skyrocketed by 51.61% to -$4.86 in 2024, then decreased by 12.68% to -$5.47 in 2025.
  • The last three reported values for Times Interest Earned were -$5.47 (Q4 2025), $0.78 (Q3 2025), and $0.71 (Q2 2025) per Business Quant data.